PrEP, PEP and doxyPEP: what is the difference?
Compare HIV prevention before and after exposure, bacterial STI prevention, testing requirements and the questions to bring to a clinician.
Compare options ↓Which prevention option do you need?
PrEP helps prevent HIV before a possible exposure. HIV PEP is an urgent course of treatment after a possible exposure. DoxyPEP uses an antibiotic after sex to reduce some bacterial STI risks for selected people. They are not different brands of the same treatment, and one cannot simply replace another. The right starting point is the concern you have today: planning ahead, responding to a recent exposure, or discussing recurring bacterial STIs.
If you think you may have been exposed to HIV within the last 72 hours, seek urgent assessment now through an emergency department, urgent-care service or sexual-health clinic that can provide PEP. Starting sooner is better; CDC advises starting ideally within 24 hours and no later than 72 hours. Do not wait for a waitlist response, a routine appointment or a delivery.
Sources: CDC: Clinical guidance for PrEP · CDC: Clinical guidance for PEP · CDC: DoxyPEP clinical guidelines
PrEP, PEP and doxyPEP compared
Use this table to understand the different purposes. It is a conversation aid, not a prescription or a self-dosing plan. A clinician still needs to assess HIV status, recent exposures, medicines and relevant health conditions. Testing and follow-up remain part of prevention, even when taking medication feels straightforward.
Sources: CDC: Clinical guidance for PrEP · CDC: Clinical guidance for PEP · CDC: DoxyPEP clinical guidelines
| Option | Main purpose | When it is used | What remains essential |
|---|---|---|---|
| PrEP | Prevent HIV in people without HIV | Before exposure; daily oral or scheduled injectable regimen | HIV testing, adherence and medicine-specific monitoring |
| HIV PEP | Reduce HIV risk after a possible exposure | Urgent assessment; start as soon as possible, no later than 72 hours | Clinician review, prescribed course and follow-up testing |
| DoxyPEP | Reduce selected bacterial STI risks | After sex for selected patients under a prescription plan | Eligibility discussion, STI screening and resistance review |
What is PrEP, and who can ask about it?
PrEP stands for pre-exposure prophylaxis. It is medication used by people without HIV to reduce the chance of acquiring HIV. Asking about PrEP does not require a particular relationship status or sexual identity. A useful discussion covers the kinds of sex you have, condom use, your partners, any injection-related exposure and whether you want additional control over HIV prevention.
CDC advises clinicians to tell sexually active patients about PrEP and prescribe it to people who request it, including people who do not report particular risk factors. That still requires appropriate assessment and testing. A negative test from months ago does not establish your status today. Tell the clinician about possible recent exposure, symptoms and any recent PrEP or PEP use, because these can change the testing pathway.
Sources: CDC: Clinical guidance for PrEP
Daily tablets or injections: how do PrEP options differ?
Daily oral options include emtricitabine with tenofovir disoproxil fumarate, often abbreviated F/TDF, and emtricitabine with tenofovir alafenamide, or F/TAF. Their approved uses and monitoring considerations differ. In particular, F/TAF is not indicated for HIV prevention through receptive vaginal sex. Your clinician should choose based on your anatomy, exposures, kidney health and other relevant factors rather than assuming that every tablet suits everyone.
Injectable cabotegravir follows an initiation schedule and then an injection every two months. Injectable lenacapavir, added to CDC recommendations in 2025, is a six-monthly option with specific initiation requirements. Longer intervals do not eliminate HIV testing, injection appointments or interaction checks. These are general clinical options; this guide does not establish that OnlyMenHealth supplies a particular product. Ask how an injection would be arranged locally and what happens if an appointment is missed.
Sources: CDC: Clinical guidance for PrEP · CDC: Lenacapavir PrEP recommendation
What tests are needed before and during PrEP?
HIV testing before treatment is essential because PrEP is not a complete treatment regimen for someone who already has HIV. Testing requirements depend on the medicine and on recent use of PrEP or PEP. For oral tenofovir-based options, kidney assessment and hepatitis B screening are important parts of evaluation. Other tests may be appropriate based on the product, your history and your sexual-health needs.
Monitoring continues after the first prescription. Oral and injectable options have different follow-up schedules. Ask for a written plan covering HIV testing, STI screening, prescription renewals and any medicine-specific laboratory checks. If travel, work or privacy concerns make repeat visits difficult, say so before choosing a regimen. Planning a realistic routine is more useful than selecting a schedule you cannot reliably follow.
Sources: CDC: Clinical guidance for PrEP · CDC: Lenacapavir PrEP recommendation
How quickly does PrEP protect you?
Protection is not identical for every medicine, exposure route or dosing approach. CDC describes daily oral PrEP reaching maximum drug levels associated with protection for receptive anal sex after about seven days of daily use. Other exposure routes can take longer, and a clinician should explain the start-up plan for your specific situation.
Do not assume one tablet taken just before sex gives immediate protection. Ask what precautions to use while starting, what to do after missed doses and how to restart after a gap. Event-driven “2-1-1” oral dosing is a separate, off-label approach that CDC does not recommend; it should not be improvised from a daily prescription. A possible recent exposure still needs an urgent PEP assessment, rather than trying to catch up on PrEP alone.
Sources: CDC: Clinical guidance for PrEP · CDC: Clinical guidance for PEP
When is HIV PEP the relevant option?
PEP means post-exposure prophylaxis. A clinician evaluates the type and timing of an exposure and whether treatment is indicated. Possible situations include a condom breaking, sexual assault or sharing injection equipment. Seeking help promptly does not commit you to a diagnosis; it gives a clinician the opportunity to assess a time-sensitive risk.
When prescribed, PEP is generally taken for 28 days, with follow-up testing and clinical review. Baseline tests matter, but indicated treatment should not be delayed while waiting for laboratory results. If exposures may continue, discuss a supported transition from PEP to PrEP. Do not borrow someone else’s medicine, stop early without advice or assume that finishing a course removes the need for follow-up testing.
Sources: CDC: Clinical guidance for PEP
Who should discuss doxyPEP?
DoxyPEP is different from HIV PEP. It uses doxycycline after sex to help prevent certain bacterial STIs; it does not prevent HIV. CDC recommends discussing its benefits and harms with gay, bisexual and other men who have sex with men, and transgender women, who have had syphilis, chlamydia or gonorrhea diagnosed in the previous 12 months.
A clinician can discuss individual circumstances outside that core group, but evidence is not equally established for every population. The decision should include side effects, other medicines, antibiotic resistance and ongoing need. If prescribed, doxyPEP is taken within a defined period after sex under the prescriber’s instructions. It is not a substitute for testing or a way to self-treat symptoms. CDC recommends reviewing ongoing need and screening for bacterial STIs every three to six months.
Sources: CDC: DoxyPEP clinical guidelines
What does prevention cost?
Compare the total care pathway, not just the medication price. Ask about the assessment, laboratory work, medicine, injection administration if applicable, delivery and follow-up. Insurance formularies, deductibles, assistance eligibility and the particular provider can change your out-of-pocket cost. A generic tablet price cannot reliably predict the total cost of an injectable program.
For context, MISTR advertises no-cost PrEP care through its insurance and patient-assistance arrangements, with STI testing tied to its PrEP or long-term HIV care services. That is an external provider example, not an OnlyMenHealth price or eligibility promise. Our pricing page separates published market examples from future OnlyMenHealth charges.
Sources: MISTR: Billing and insurance FAQs
What should you bring to a prevention appointment?
Write down the date of any recent exposure, your latest test dates, current medicines and supplements, and any past reactions to medication. Include practical concerns: taking a daily pill discreetly, attending injection appointments, travel, insurance communications or keeping deliveries private. You can ask why a question matters if it feels intrusive.
Before leaving, make sure you know the next testing date, how to report side effects, what to do after missed medication and who will explain results. A prevention plan should be understandable without relying on memory. Keep urgent exposure care separate from a general website enquiry, and use a dedicated clinical channel when sharing health information.
Sources: CDC: Clinical guidance for PrEP · CDC: Clinical guidance for PEP
Frequently asked questions
Does PrEP prevent every STI?
No. PrEP is for HIV prevention. It does not prevent infections such as gonorrhea, chlamydia or syphilis. Discuss condoms, screening and other appropriate prevention options alongside PrEP.
Can doxyPEP replace HIV PEP?
No. DoxyPEP targets selected bacterial STIs, while HIV PEP uses antiretroviral medication after a possible HIV exposure. Seek urgent assessment for possible HIV exposure within 72 hours.
Can I choose an injection instead of daily pills?
It may be an option after clinical assessment. Cabotegravir and lenacapavir have different schedules, testing requirements and interaction considerations. Local access and the ability to attend appointments also matter.
Can I stop PrEP when my circumstances change?
Discuss stopping or switching with your clinician. The timing depends on the regimen and ongoing exposure, and stopping certain oral medicines also matters if you have hepatitis B. Injectable medicines require a plan for declining drug levels.
Does joining the waitlist start a clinical assessment?
No. The waitlist records an email address and consent for launch updates. It does not provide HIV testing, a prescription, an appointment or urgent medical care.
Sources and editorial notes
Updated November 5, 2026. Educational content from the OnlyMenHealth editorial team. This page does not replace an individual assessment or imply clinical review by a named provider.
Get OnlyMenHealth launch updates
Use our single email waitlist for availability and pricing updates. For symptoms or urgent exposure concerns, contact an appropriate clinical service.